Market Place
Sourcing Support
All News #Library
Biotech
Amicus Reveals Extended Data on Galafold and Pombiliti + Opfolda
03 Feb 2026 //
GLOBENEWSWIRE
4-Year Data for Pombiliti and Opfolda Presented at ICIEM
08 Sep 2025 //
GLOBENEWSWIRE
Amicus Therapeutics` Pombiliti® and Opfolda® Approved in Japan
25 Jun 2025 //
GLOBENEWSWIRE
Amicus Reports 2024 Financial Results, Corporate Updates
19 Feb 2025 //
GLOBENEWSWIRE
Amicus Therapeutic Launches Amicus Ignite For Pompe Disease Support
31 Jan 2025 //
PHARMAWEB
Amicus Therapeutics Reports 2024 Revenue & Strategic Outlook
12 Jan 2025 //
GLOBENEWSWIRE
Amicus to Present at 43rd Annual J.P. Morgan Conference
02 Jan 2025 //
GLOBENEWSWIRE
Amicus Therapeutics Announces Q3 2024 Financial Results & Updates
06 Nov 2024 //
GLOBENEWSWIRE
Amicus Therapeutics to Present at November Investor Conferences
01 Nov 2024 //
GLOBENEWSWIRE
Amicus Therapeutics Announces Participation At Muscle Congress
04 Oct 2024 //
GLOBENEWSWIRE
Amicus Therapeutics Announces Q2 2024 Results And Corporate Updates
08 Aug 2024 //
GLOBENEWSWIRE
Amicus scores $430M financing deal with asset manager Blackstone
03 Oct 2023 //
FIERCE PHARMA
WuXi Congratulates Amicus on ECA for Pombiliti
28 Mar 2023 //
PRESS RELEASE
Amicus Announces Positive Data from PIII Open-label Extension Study of AT-GAA
22 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.